Bharat Parenterals Shareholders Approve Preferential Issue and Enhanced Investment Limits
Bharat Parenterals Ltd 路 Extra Ordinary General Meeting 路 24 Oct 2026, 11:09 pm
Bharat Parenterals Shareholders Approve Preferential Issue and Enhanced Investment Limits Bharat Parenterals Limited announced that shareholders approved two special resolutions at its Extraordinary General Meeting held on 23rd Oct'26. The passed resolutions include the issuance of equity shares on a preferential basis and authorization to exceed investment, loan, guarantee, and security limits under Section 186(2) of the Companies Act, 2013. Both proposals were passed unanimously via remote e-voting, with 100% of the 4,879,194 polled votes cast in favor, representing 70.80% of total outstanding shares across 69 voting members.
Original exchange filing (PDF)
More announcements from Bharat Parenterals Ltd
- Intimation for receipt of Establishment Inspection Report from US FDA by Innoxel Lifesciences Pvt Ltd., a subsidiary company of Bharat Parenterals Limited. 路 05 Nov 2026
- Transcript of Earnings Conference Call of Q2FY27. 路 02 Nov 2026
- Audio Recording of Q2FY27 Earnings Conference Call. 路 30 Oct 2026
- Investor Presentation for the Quarter and Half Year ended on September 30, 2026. 路 29 Oct 2026
- Un-Audited Standalone and Consolidated Financial Results For the Quarter and Half Year Ended On September 30, 2026. 路 29 Oct 2026
- Outcome of the Meeting of the Board of Director of Bharat Parenterals Limited held on October 29, 2026 路 29 Oct 2026
- Approval of Preferential Issue by Shareholders of the Company through EGM Held on October 23, 2026. 路 25 Oct 2026
- Revised Voting Result 路 25 Oct 2026
